Program Steering Committee. The Program Steering Committee (the “Program Steering Committee”) will oversee activities under the Master Development Plans and the Research Collaboration.
Program Steering Committee. 4.1 The Parties hereby form a program steering committee (the “PSC”), consisting initially of [*] designated by Zealand, and [*] designated by Protagonist.
4.2 The PSC will consist at all times of an equal number of representatives of each Party. Each Party may at any time appoint different PSC representatives by written notice to the other Party. The chairperson shall be appointed by Zealand from amongst the PRC representatives.
4.3 Upon mutual consent of the Parties, the PSC may increase its membership and form sub committees as it deems appropriate. Such sub-committees may meet more frequently than the PSC itself.
4.4 The PSC shall meet in person or via telephone or other means of telecommunication at least two (2) times during each year. The chairperson of the PSC will be responsible for calling meetings and preparing and circulating an agenda in advance of each meeting, and for preparing, circulating and receiving comments on a draft minutes of each meeting, in each case applying the provisions of Section 3.2.4 mutatis mutandis.
4.5 During the Research Term the PSC shall be a forum for discussion of items not resolved by the JRC.
4.6 After the Research Term and for the Term of this Agreement, the PSC shall be a forum for the exchange of information between the Parties, and discussion and comment by Protagonist thereof, concerning the development, commercialization and/or partnering of Selected DRPs, Therapeutic Peptides and/or Products (including the coordination of the exchange and discussion of the Summary Plan between the Parties), and to: (i) provide consultation to the Parties concerning the protection of the Research IP; and (ii) provide consultation to the Parties regarding the exchange and appropriate publication of scientific data generated as a result of the activities conducted pursuant to the Research Plan or otherwise under this Agreement. In the event that Protagonist exercises the Co-Financing Option the PSC shall also be a forum for the timely exchange of information between the Parties, and discussion and comment by Protagonist thereof, concerning the development plans, including the planning and progress (including financial) thereof and results obtained therefrom, for the Products in relation to which the Co-Financing Option has been exercised (including timely information on proposed changes to such development plans, material events and changes to the expected cost- or time-breakdown for such development plans). Information shall ...
Program Steering Committee. The Program Steering Committee (the “Program Steering Committee”) will oversee activities under the revised Master Development Plans.
4.2 The Program Steering Committee shall meet one time, no later than one hundred and eighty (180) days after SoPD for the first Replacement Collaboration Compound. With the exception of this post-SoPD meeting, the meetings of the Program Steering Committee shall be suspended until the earlier of (a) the Filing with the U.S. Food and Drug Administration of the first Investigational New Drug Application for the first Replacement Collaboration Compound for ZP2929, or (b) the first ethical committee approval of a Phase I Clinical trial for the first Replacement Collaboration Compound for ZP2929. Thereafter, the Program Steering Committee shall meet as further outlined in Section 2.3 of the GGDA Agreement.
4.3 For so long as meetings of the Program Steering Committee are suspended as provided in Section 4.2 above, BI’s research team (until. SoPD) and BI’s development team (after SoPD) shall provide Zealand Pharma’s research team, every six (6) months after the Amendment 2 Effective Date, with a summary update in reasonable detail about its research activities for candidate Replacement Collaboration Compounds and its performance of the Summary Research Plan.. Such summary reports shall include the items described in Appendix 4.3 to this Amendment 2. In order to ensure an efficient exchange of information relevant to the Summary Research Plan, should Zealand Pharma so request, not more than three (3) designees from the research teams of each of BI and. Zealand Pharma shall meet by videoconference or telephone conference once in each of the first and third Calendar Quarters, to discuss the status of and path forward for BI’s research activities.
Program Steering Committee. Hydro Ottawa, the Greater Ottawa Home Builders Association, the Ottawa Climate Action Fund, and the Community Associations for the Environment Sustainability all sit on the program steering committee and have committed to supporting the launch, implementation and review of the program.
Program Steering Committee. The Program Executing Agency shall establish the PSC to be chaired by the State Secretary, MoF. The members of the PSC shall be the senior representatives of the implementing agencies. The PSC shall (a) monitor the Program; and (b) provide policy and strategic guidance.
Program Steering Committee. The program steering committee will prioritize the work efforts in conjunction with the Client Contract Manager and the Supplier Contract Manager.
Program Steering Committee. The Program Implementing Entity shall maintain, until the completion of the Program, a Program Steering Committee, chaired by the Chief Secretary and Principal Secretaries of the Department of Finance and all the Implementing Agencies, with composition, resources, and terms of reference acceptable to the Bank, to provide strategic guidance for implementing the Program, reform initiatives and support enhanced collaboration.
Program Steering Committee. 4.1 The Parties hereby form a program steering committee (the “PSC”), consisting initially of [*] designated by Zealand, and [*] designated by Protagonist.
4.2 The PSC will consist at all times of an equal number of representatives of each Party. Each Party may at any time appoint different PSC representatives by written notice to the other Party. The chairperson shall be appointed by Zealand from amongst the PRC representatives.
4.3 Upon mutual consent of the Parties, the PSC may increase its membership and form sub committees as it deems appropriate. Such sub-committees may meet more frequently than the PSC itself.
4.4 The PSC shall meet in person or via telephone or other means of telecommunication at least two (2) times during each year. The chairperson of the PSC will be responsible for calling meetings and preparing and circulating an agenda in advance of each meeting, and for preparing, circulating and receiving comments on a draft minutes of each meeting, in each case applying the provisions of Section 3.2.4
Program Steering Committee. (a) the Recipient shall maintain, throughout the implementation of the Program, a steering committee (“Program Steering Committee”), with a composition, mandate, and resources acceptable to the Association, and which shall be chaired by the Permanent Secretary of the Ministry of Energy; and
(b) without limitation to sub-paragraph (a) immediately above, the Program Steering Committee shall be responsible for, inter alia: (i) providing strategic guidance and oversight to ensure prompt and efficient implementation of the Program; and (ii) ensuring overall coordination of Program implementation, all in accordance with the provisions of the Program Operations Manual.
Program Steering Committee. At an appropriate time, but no later than a reasonable period following the conclusion of [***], the parties will establish a steering committee to advise on the conduct of clinical trials of the Licensed Products, in accordance with this Section 3.5 (the “Program Steering Committee”). One University faculty member will be appointed by University to serve as co-chair of the Program Steering Committee, which provides University the opportunity to be a [***] participant in the design and conduct of clinical trials of Licensed Products. The other co-chair will be appointed by the Company. The Program Steering Committee will include other members from the scientific and clinical community with relevant experience in the conduct of clinical trials of cell therapy products. The total number of members will be approximately [***] people. Either co-chair can recommend members for participation on the Program Steering Committee, provided that the final identity and total number of members will be determined by the Company in its sole discretion. The Company will have the sole responsibility for establishing contractual relationships (e.g. CDA and consulting agreements) with the members and for providing compensation, if any, to the members. The roles of the Program Steering Committee include but are not limited to the following activities relevant to clinical trials of Licensed Products: [***] Notwithstanding anything to the contrary, the Program Steering Committee is advisory in nature only. Final decision-making regarding matters discussed or presented to the Program Steering Committee with rest with Company acting in its sole discretion.”
2.7 Section 5.1
